Biotech BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule April 11, 2024
Biotech J INTS BIO, AACR 2024 – ‘JIN-A02’, a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study April 11, 2024
Biotech Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer April 11, 2024
Biotech BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn’s® Phase 3 Clinical Trial in ALS April 10, 2024
Biotech Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine’s Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024 April 10, 2024
Biotech PRENOSIS ANNOUNCES COMMERCIAL DISTRIBUTION COLLABORATION WITH ROCHE FOR SEPSIS IMMUNOSCORE™, THE FIRST FDA DE NOVO AUTHORIZED ARTIFICIAL INTELLIGENCE TOOL FOR SEPSIS DETECTION April 10, 2024
Biotech MGI Tech Crowned in GHP’s Biotechnology Awards 2024 as the Most Innovative Next-Gen Sequencing Company April 10, 2024
Biotech ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research April 10, 2024
Biotech BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS April 9, 2024
Search
Biotech
April 11, 2024
April 11, 2024
April 11, 2024
April 10, 2024
April 10, 2024
April 10, 2024
April 10, 2024
April 10, 2024
April 9, 2024
April 9, 2024
